(RTTNews) - Medicus Pharma Ltd (MDCX) announced that it has submitted a Phase 2 clinical trial design or SKNJCT-004 to the UAE Department of Health or DOH for its non-invasive treatment for Basal Cell ...
“The United Kingdom regulatory and ethical approval is another major step forward in establishing a global footprint of our novel, non-invasive treatment for BCC of the skin, which we believe ...
“The United Kingdom regulatory and ethical approval is another major step forward in establishing a global footprint of our novel, non-invasive treatment for BCC of the skin, which we believe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results